Insiders · Profile

Raday Gilead

Chief Operating Officer at RedHill Biopharma. Filing since 6 Apr 2026. CIK 0002113137

Company
Date
Role
Action
Shares
Amount
Of holding
1 Oct 2026
Chief Operating Officer
Sold at will
14,310,000
$1.43K
7.5%
10 Jul 2026
Chief Operating Officer
Sold at will
14,130,000
$1.41K
6.1%
6 Apr 2026
Chief Operating Officer
Sold at will
15,740,000
$1.57K
5.7%
3 decisions on file.